Published 11th July 2016

New funding round for Abingdon Health

Imperial Innovations has led a £3 million funding round into portfolio company Abingdon Health Ltd, a specialist medical diagnostics company.

The fundraising will support the commercialisation of the Group’s recently launched products in the area of multiple myeloma testing.

Chris Yates, CEO of Abingdon Health, commented: “The successful completion of this funding round, coupled with the recent announcement of the global distribution agreement with Sebia, are significant milestones for the Group, and will support the commercialisation of its Seralite®– FLC assays.”

Learn more about Abingdon Health and its pipeline